Identification |
Name: | 2(1H)-Isoquinolinecarboxylicacid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester,hydrochloride (1:1), (1S)- |
Synonyms: | 2(1H)-Isoquinolinecarboxylicacid, 3,4-dihydro-1-phenyl-, (3R)-1-azabicyclo[2.2.2]oct-3-yl ester,monohydrochloride, (1S)- (9CI); 2(1H)-Isoquinolinecarboxylic acid,3,4-dihydro-1-phenyl-, 1-azabicyclo[2.2.2]oct-3-yl ester, monohydrochloride,[R-(R*,S*)]-; Solifenacin hydrochloride |
CAS: | 180468-39-7 |
Molecular Formula: | C23H26 N2 O2 . Cl H |
Molecular Weight: | 0 |
InChI: | InChI=1/C23H26N2O2.ClH/c26-23(27-21-16-24-13-10-18(21)11-14-24)25-15-12-17-6-4-5-9-20(17)22(25)19-7-2-1-3-8-19;/h1-9,18,21-22H,10-16H2;1H/t21-,22-;/m0./s1 |
Molecular Structure: |
|
Properties |
Flash Point: | 259.5°C |
Boiling Point: | 505.5°Cat760mmHg |
Density: | g/cm3 |
Flash Point: | 259.5°C |
Usage: | Muscarinic M3 receptor antagoinst. Used in treatment of urinary incontinence |
Safety Data |
|
|